Martin Braddock Email

Martin Braddock Work

• 2026 -now Advisor @ Mass Balance
• 2025 -now Associate Professor @ University of Information Technology & Management in Rzeszow, Poland
• 2024 -now Founder and Director @ GENIXICONSULTING LTD
• 2020 -2024 Global Products Leader Symbicort Aerosphere and Established Respiratory Brands; Symbicort, Pulmicort @ AstraZeneca
• 2021 -2021 Programme reviewer @ Ministero della Salute
• 2020 -2020 Global Product Leader, Late Respiratory and Immunology, BioPharmaceuticals R and D @ AstraZeneca
• 2018 -2020 Global Product Leader, Late Development Respiratory and Immunology @ AstraZeneca
• 2017 -2018 Global Products Manager - Tezepelumab @ AstraZeneca
• 2016 -2018 Global Products Manager - Tralokinumab @ AstraZeneca
  View Department
• 2013 -2016 Clinical Science Director @ AstraZeneca
• 2013 -2016 Senior Principal Scientist Late Stage Development Projects @ AstraZeneca
  View Department
• 2004 -2016 Senior Principal Scientist @ AstraZeneca
• 2010 -2013 Fostamatinib Global Development Team Science Lead, Drug Development @ AstraZeneca
  View Department
• 2009 -2011 Leader Global Biology Network @ AstraZeneca
• 2006 -2008 Director, Discovery Bioscience @ AstraZeneca
• 2001 -2008 Global Project Leader - Drug Discovery @ AstraZeneca
  View Department
• 2000 -2006 Associate Director @ AstraZeneca
• 2004 -2006 Global Leader Disease Strategy Team - Inflammation @ AstraZeneca
• 1999 -2000 Head Disease Sciences Unit @ GSK
• 1998 -2000 Programme Leader, Wound Repair and Tissue Regeneration @ GSK
• 1998 -2000 Joint Steering Committee Member @ GSK
• 1995 -1998 Team Leader @ GSK
• 1991 -1995 Royal Society Research Fellow @ Oxford Women in Physics
• 1992 -1993 Senior Tutor @ Hertford College, University of Oxford
• 1987 -1991 Post-doctoral Research Fellow @ Oxford Women in Physics
• 1984 -1987 Post-doctoral Research Fellow @ University of Dundee